On Invalid Date, Avadel Pharmaceuticals (NASDAQ: AVDL) reported Q4 2023 earnings per share (EPS) of -$0.29, up 34.09% year over year. Total Avadel Pharmaceuticals earnings for the quarter were -$28.79 million. In the same quarter last year, Avadel Pharmaceuticals's earnings per share (EPS) was -$0.44.
As of Q2 2024, Avadel Pharmaceuticals's earnings has grown year over year. Avadel Pharmaceuticals's earnings in the past year totalled -$160.28 million.
What is AVDL's earnings date?
Avadel Pharmaceuticals's earnings date is Invalid Date. Add AVDL to your watchlist to be reminded of AVDL's next earnings announcement.
What was AVDL's revenue last quarter?
On Invalid Date, Avadel Pharmaceuticals (NASDAQ: AVDL) reported Q4 2023 revenue of $19.45 million up Infinity% year over year. In the same quarter last year, Avadel Pharmaceuticals's revenue was $0.00.
What was AVDL's revenue growth in the past year?
As of Q2 2024, Avadel Pharmaceuticals's revenue has grown null year over year. Avadel Pharmaceuticals's revenue in the past year totalled $27.96 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.